Form 4: Guardant Health CIO Reports Routine Stock Vesting and Tax Withholding

Guardant Health's Chief Information Officer, Kumud Kalia, reported the acquisition of shares through Restricted Stock Unit vesting and the subsequent disposition of shares for tax obligations.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc. (GH), reported transactions on July 1, 2025, related to her beneficial ownership.
• Kalia acquired 1,607 shares of common stock through the vesting of a Restricted Stock Unit (RSU) award granted on November 7, 2022.
• An additional 1,084 shares of common stock were acquired through the vesting of another RSU award granted on December 13, 2023.
• Concurrently, 1,365 shares of common stock were disposed of at a price of $50.71 per share to satisfy tax withholding obligations associated with the RSU vesting.
• Following these reported transactions, Kumud Kalia beneficially owns 20,500 shares of Guardant Health common stock.
• Kalia also holds 8,035 unvested Restricted Stock Units from the November 7, 2022 award and 5,419 unvested Restricted Stock Units from the December 13, 2023 award.

Sentiment

Score: 5

Explanation: The document reports a routine insider transaction related to executive compensation, which is neither inherently positive nor negative for the company's operational or financial performance.

Positives

• The vesting of Restricted Stock Units indicates the fulfillment of compensation agreements and continued employment of a key executive.
• The acquisition of shares through RSU vesting increases the executive's direct stake in the company, aligning interests with shareholders.

Negatives

• A portion of the vested shares (1,365 shares) was disposed of to cover tax withholding, which reduces the net increase in the executive's direct ownership.

Future Outlook

Remaining portions of the Restricted Stock Unit awards are scheduled to vest in equal quarterly installments over the next two to three years. Specifically, 75% of the November 7, 2022 award will vest over the remaining three-year period after October 1, 2023, and 67% of the December 13, 2023 award will vest over the remaining two-year period after October 1, 2024.

Industry Context

This Form 4 filing reflects a routine insider transaction related to executive compensation, which is a common occurrence across publicly traded companies as part of their equity incentive plans. It does not provide insights into broader industry trends but rather specific compensation events for a key executive at Guardant Health.

Related Party Transactions

• The transactions involve the vesting of Restricted Stock Units (RSUs) granted by Guardant Health, Inc. to its Chief Information Officer, Kumud Kalia, as part of her compensation package. This includes the company retaining shares to cover tax withholding obligations.

Stakeholder Impact

• Shareholders: The transaction is a routine part of executive compensation and has a minimal direct impact on the overall share structure or value. It aligns the executive's interests with shareholders through equity ownership.
• Employees: Reflects standard compensation practices for executives, which may set a precedent or expectation for equity-based incentives within the company.

Next Steps

• Future quarterly vesting of the remaining Restricted Stock Units for Kumud Kalia, as per the original award schedules.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Vesting, Tax Withholding, Kumud Kalia, Chief Information Officer, Beneficial Ownership